血清维生素D水平与认知障碍^*

Associations between serum vitamin D levels and cognitive impairment: insights from recent studies

摘要

认知障碍的发生率随全球老龄化进程的加快而不断上升, 不仅影响了患者的生活质量, 也给家庭和社会带来了沉重的负担。脂溶性维生素D具有潜在神经保护作用, 其缺乏可能引起认知功能, 如记忆、学习能力的下降。本文综述维生素D的作用及其缺乏对认知功能障碍的影响, 旨在为该类疾病的预防和治疗提供参考。

Abstract

The acceleration of global aging is leading to constant increase in the frequency of cognitive impairment, adversely affecting patients' quality of life and imposing a significant burden on families and society. The possible neuroprotective effects of vitamin D, an essential fat-soluble vitamin, have attracted significant interest. Current research indicates that a shortage in vitamin D may correlate with deficiencies in cognitive functions, particularly evident as deficiencies in memory, learning, and other cognitive capacities. This review intends to evaluate the present condition of vitamin D insufficiency and its effects on cognitive impairment, with the objective of offering references for the prevention and treatment of these disorders.

关键词

维生素D / 老年人 / 认知障碍 / 神经保护

Key words

Vitamin D / Elderly / Cognitive impairment / Neuroprotection

参考文献

[1] Rihal V, Khan H, Kaur A, et al. Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders[J]. Psychiatry Res, 2022, 317: 114782.

[2] Arosio B, Rossi P D, Ferri E, et al. Characterization of vitamin D status in older persons with cognitive impairment[J]. Nutrients, 2022, 14(6): 1142.

[3] Yang T, Wang H, Xiong Y, et al. Vitamin D supplementation improves cognitive function through reducing oxidative stress regulated by telomere length in older adults with mild cognitive impairment: a 12—month randomized controlled trial[J]. J Alzheimers Dis, 2020, 78(4): 1509-1518.

[4] Guo J, Mo H, Zuo L, et al. Association of physical activity and vitamin D deficiency with cognitive impairment in older adults: a population based cross—sectional analysis[J]. Front Nutr, 2024, 11: 1390903.

[5] 桑丹卓嘎, 郑松柏 . 维生素D与老年疾病[J]. 国际老年医学杂志, 2023, 44(1): 82-86.

[6] Sangdan Z G, Zheng S B. Vitamin D and age—related diseases[J]. Int J Geriatr, 2023, 44(1): 82-86.

[7] Yao Y, Fu S, Li N, et al. Sex, residence and fish intake predict vitamin D status in Chinese centenarians[J]. J Nutr Health Aging, 2019, 23(2): 165-171.

[8] Matsuo L H, Confortin S C, Ceolin G, et al. Association between lower serum vitamin D (25—hydroxy—cholecalciferol) concentrations and cognitive impairment in older adults: data from a populational—based cohort study in a middle—income country[J]. Public Health Nutr, 2022, 25(9): 2507-2516.

[9] Hoseinzadeh—Chahkandak F, Zeinali T, Salmani F, et al. Prevalence of vitamin D deficiency and its association with metabolic syndrome among the elderly population of Birjand, Iran[J]. J Diabetes Metab Disord, 2022, 21(1): 475-481.

[10] Jones A, Ali M U, Kenny M, et al. Potentially modifiable risk factors for dementia and mild cognitive impairment: an umbrella review and meta—snalysis[J]. Dement Geriatr Cogn Disord, 2024, 53(2): 91-106.

[11] Dai M, Song Q, Wang X, et al. Combined associations of vitamin D and cognitive function with all—cause mortality among older adults in Chinese longevity areas: a prospective cohort study[J]. Front Public Health, 2023, 11: 1024341.

[12] Khairy E Y, Saad A . Relationship between the thrombospondin—1/Toll—like receptor 4 (TSP1/TLR4) pathway and vitamin D levels in obese and normal weight subjects with different metabolic phenotypes[J]. J Physiol Sci, 2023, 73(1): 29.

[13] Matias M L, Romao—Veiga M, Ribeiro V R, et al. Progesterone and vitamin D downregulate the activation of the NLRP1/NLRP3 inflammasomes and TLR4—MyD88—NF—κB pathway in monocytes from pregnant women with preeclampsia[J]. J Reprod Immunol, 2021, 144: 103286.

[14] Custódio G, Schwarz P, Crispim D, et al. Association between vitamin D levels and inflammatory activity in brain death: a prospective study[J]. Transpl Immunol, 2018, 48: 65-69.

[15] Poh L, Sim W L, Jo D G, et al. The role of inflammasomes in vascular cognitive impairment[J]. Mol Neurodegener, 2022, 17(1): 4.

[16] Toppi E, Sireno L, Lembo M, et al. IL—33 and IL—10 serum levels increase in MCI patients following homotaurine treatment[J]. Front Immunol, 2022, 13: 813951.

[17] Ciobanu A M, Petrescu C, Anghele C, et al. Severe vitamin D deficiency—a possible cause of resistance to treatment in psychiatric pathology[J]. Medicina (Kaunas), 2023, 59(12): 2056.

[18] Shirazi H A, Rasouli J, Ciric B, et al. 1,25—dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation[J]. Exp Mol Pathol, 2015, 98(2): 240-245.

[19] Sun Y, Pu Z, Zhao H, et al. Vitamin D can mitigate sepsis—associated neurodegeneration by inhibiting exogenous histone—induced pyroptosis and ferroptosis: implications for brain protection and cognitive preservation[J]. Brain Behav Immun, 2025, 124: 40-54.

[20] AlJohri R, AlOkail M, Haq S H . Neuroprotective role of vitamin D in primary neuronal cortical culture[J]. eNeurologicalSci, 2019, 14: 43-48.

[21] Zhang X X, Wang H R, Meng W, et al. Association of vitamin D levels with risk of cognitive impairment and dementia: a systematic review and meta—analysis of prospective studies[J]. J Alzheimers Dis, 2024, 98(2): 373-385.

[22] Kim D H, Meza C A, Clarke H, et al. Vitamin D and endothelial function[J]. Nutrients, 2020, 12(2): 575.

[23] Vahidinia Z, Karimian M, Joghataei M T . Neurosteroids and their receptors in ischemic stroke: from molecular mechanisms to therapeutic opportunities[J]. Pharmacol Res, 2020, 160: 105163.

[24] Zhu D M, Zhao W, Cui S, et al. The relationship between vitamin D, clinical manifestations, and functional network connectivity in female patients with major depressive disorder[J]. Front Aging Neurosci, 2022, 14: 817607.

[25] Liu X, Zhao W, Hu F, et al. Comorbid anxiety and depression, depression, and anxiety in comparison in multiethnic community of west China: prevalence, metabolic profile, and related factors[J]. J Affect Disord, 2022, 298(Pt A): 381-387.

[26] Fond G, Faugere M, Faget—Agius C, et al. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia[J]. Eur Arch Psychiatry Clin Neurosci, 2019, 269(8): 879-886.

[27] Patrick R P, Ames B N. Vitamin D and the omega—3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior[J]. FASEB J, 2015, 29(6): 2207-2222.

[28] Sangha A, Quon M, Pfeffer G, et al. The role of vitamin D in neuroprotection in multiple sclerosis: an update[J]. Nutrients, 2023, 15(13): 2978.

[29] Charoenporn V, Tungsukruthai P, Teacharushatakit P, et al. Effects of an 8—week high—dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post—COVID syndrome: a randomized controlled trial[J]. Psychiatry Clin Neurosci, 2024, 78(10): 595-604.

[30] Soyak H M, Karakükcü Ç . Investıgation of vitamin D levels in obsessive—compulsive disorder[J]. Indian J Psychiatry, 2022, 64(4): 349-353.

[31] Anilkumar S A, Dutta S, Aboo S, et al. Vitamin D as a modulator of molecular pathways involved in CVDs: evidence from preclinical studies[J]. Life Sci, 2024, 357: 123062.

[32] Li B, Wang Y, Jiang X, et al. Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease[J]. Biomed Pharmacother, 2023, 164: 114950.

[33] Han B, Jiang W, Liu H, et al. Upregulation of neuronal PGC—1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion[J]. Theranostics, 2020, 10(6): 2832-2848.

[34] Valls—Pedret C, Sala—Vila A, Serra—Mir M, et al. Mediterranean diet and age—related cognitive decline: a randomized clinical trial[J]. JAMA Intern Med, 2015, 175(7): 1094-1103.

[35] Uthaiah C A, Devaru N C, Shivakumar N H, et al. Vitamin D mitigates hyperglycemia—induced cognition decline in Danio rerio (Zebrafish) through the activation of antioxidant mechanisms[J]. Antioxidants (Basel), 2022, 11(11): 2114.

[36] Gómez—Oliva R, Geribaldi—Doldán N, Domínguez—García S, et al. Vitamin D deficiency as a potential risk factor for accelerated aging, impaired hippocampal neurogenesis and cognitive decline: a role for Wnt/β—catenin signaling[J]. Aging (Albany NY), 2020, 12(13): 13824-13844.

[37] Zaulkffali A S, Md Razip N N, Syed Alwi S S, et al. Vitamins D and E stimulate the PI3K—AKT signalling pathway in insulin—resistant SK—N—SH neuronal cells[J]. Nutrients, 2019, 11(10): 2525.

[38] Supriya M, Christopher R, Prabhakar P, et al. Low vitamin D status is associated with inflammatory response in older patients with cerebral small vessel disease[J]. J Neuroimmunol, 2023, 377: 578057.

[39] Zhao W, Zhu D M, Li Q, et al. Brain function mediates the association between low vitamin D and neurocognitive status in female patients with major depressive disorder[J]. Psychol Med, 2023, 53(9): 4032-4045.

[40] Kang J, Park M, Lee E, et al. The role of vitamin D in Alzheimer's disease: a transcriptional regulator of amyloid—opathy and gliopathy[J]. Biomedicines, 2022, 10(8): 1824.

基金资助

^*北京市自然科学基金项目(52222004)